Back to search

Article

Mechanistic Study of Yang-gan-jie-yu Granules in Treating Postmenopausal Metabolic-Associated Fatty Liver Disease Based on Transcriptomics and Network Pharmacology

2025-07-02

Abstract excerpt

<h4>Objective: </h4> This study aimed to evaluate the therapeutic effects of Yang-gan-jie-yu Granules (YGJY) on a high-fat diet-induced postmenopausal metabolic-associated fatty liver disease (MAFLD) rat model, and to investigate the underlying mechanism of hepatic steatosis amelioration through integrated transcriptomic and network pharmacology approaches. <h4>Methods:</h4> Ultra-high-performance liquid chromatog...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
63d50999-cac4-552e-b025-e076df1575ac
DOI
10.22541/au.175145777.79343900/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mechanistic Study of Yang-gan-jie-yu Granules in Treating Postmenopausal Metabolic-Associated Fatty Liver Disease Based on Transcriptomics and Network PharmacologyDOI 10.22541/au.175145777.79343900/v1
Therapeutic Mechanisms of Medicine and Food Homology Formula Xiao-Ke-Yin on Glucolipid Metabolic Dysfunction Revealed by Transcriptomics, Metabolomics and Microbiomics in miceSemantic proximity
<i>Patolakaturohiniyadi Kashayam</i> , exerts anti-steatotic and anti-obesogenic effects via coordinated regulation of lipid metabolism, inflammation, and incretin signallingSemantic proximity
The Study of Yin-Chen-Hao-Tang Preventing and Treating Alcoholic Fatty Liver Disease Through PPAR Signaling Pathway Based on Network Pharmacology and RNA-Seq TranscriptomicsSemantic proximity
Explore of potential targets and mechanisms of hesperetin in treating metabolic dysfunction-associated steatosis liver disease via network pharmacology and in vitro experimentsSemantic proximity
Effects of Gynostemma pentaphyllum on hypolipidemic and the mechanism of network pharmacology and molecular docking in treating hyperlipidaemiaSemantic proximity
Transcriptome and translatome analyses reveal the regulatory role of betaine in high fat diet (HFD)-induced hepatic steatosisSemantic proximity
LncNONMMUG027912 alleviates lipid accumulation through AMPKα/mTOR/SREBP1C axis in nonalcoholic fatty liverSemantic proximity
Identify Key Active Ingredients and Molecular Mechanisms of Jiangzhi Decoction on Non-alcoholic Fatty Liver Disease by Network Pharmacology AnalysisSemantic proximity
Mechanisms of Cynarine for treatment of Non-alcoholic Fatty Liver Disease Based on the Integration of Network Pharmacology, Molecular Docking and Cell ExperimentSemantic proximity
Multi-omics analysis reveals gut microbiota remodeling and lipid metabolism regulation during the treatment of nonalcoholic fatty liver disease with Yindan Pinggan capsuleSemantic proximity
The Effect of Cardiometabolic Drugs on Non-Alcoholic Fatty Liver Disease (NAFLD), Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Semantic proximity
Exploring anti-nonalcoholic fatty liver disease mechanism of Gardeniae Fructus by combining an animal model with network pharmacology and molecular dockingSemantic proximity
Select a neighboring publication to make it the new centre.